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Neurobiology of Disease
Cross-Recognition of a Myelin Peptide by CD8 T Cells in the
CNS Is Not Sufficient to Promote Neuronal Damage
Eva Reuter,1* Rene´ Gollan,1* XNadia Grohmann,3,4* Magdalena Paterka,1,3 XHe´le`ne Salmon,4 Je´roˆme Birkenstock,1
Sebastian Richers,2 Tina Leuenberger,1,3 Alexander U. Brandt,3,4 Tanja Kuhlmann,5 XFrauke Zipp,1,3†
and Volker Siffrin1,3,4†
1Department of Neurology, Research Center Translational Neurosciences, Rhine Main Neuroscience Network (rmn2), and 2Institute of Microanatomy and
Neurobiology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany, 3Molecular Neurology Group, Max
Delbrueck Center for Molecular Medicine Berlin-Buch, 13125 Berlin, Germany, 4Charite´ University Medicine Berlin, ECRC, 13125 Berlin, Germany, and
5Institute of Neuropathology, University Hospital Mu¨nster, 48149 Mu¨nster, Germany
Multiple sclerosis (MS) is an inflammatorydisease of theCNS thought tobedrivenbyCNS-specific T lymphocytes.AlthoughCD8Tcells
are frequently found in multiple sclerosis lesions, their distinct role remains controversial because direct signs of cytotoxicity have not
been confirmed in vivo. In the presentwork, we determined thatmurine ovalbumin-transgenic (OT-1) CD8T cells recognize themyelin
peptidemyelin oligodendrocyte glycoprotein 40–54 (MOG40–54) both in vitro and in vivo. The aimof this studywas to investigatewhether
such cross-recognizing CD8 T cells are capable of inducing CNS damage in vivo. Using intravital two-photonmicroscopy in themouse
model of multiple sclerosis, we detected antigen recognition motility of the OT-1 CD8 T cells within the CNS leading to a selective
enrichment in inflammatory lesions. However, this cross-reactivity of OT-1 CD8 T cells with MOG peptide in the CNS did not result in
clinically or subclinically significant damage, which is different from myelin-specific CD4 Th17-mediated autoimmune pathology.
Therefore, intravital imagingdemonstrates that localmyelin recognitionbyautoreactiveCD8Tcells in inflammatoryCNS lesions alone
is not sufficient to induce disability or increase axonal injury.
Key words: CD8 T cells; EAE/MS; intravital microscopy; molecular mimicry
Introduction
Reports of the presence of CD8 T cells in multiple sclerosis
lesions (Babbe et al., 2000; Siewert et al., 2012) have suggested a
crucial role for these cells in the initiation and/or damage pro-
cesses of the disease (Friese and Fugger, 2009; Huseby et al.,
2012). A popular hypothesis for how T cells mediate autoim-
munity is molecular mimicry; that is, that infections with
certain pathogens drive adaptive immune-cell responses, re-
sulting in cross-recognition of foreign and self-antigens
(Benoist and Mathis, 2001). In fact, reports about cross-
reactive T cells in multiple sclerosis are frequent, but in vivo
proof of a causative link to the disease has not yet been found
(Cusick et al., 2013).
Specific interaction of CD8 T cells with target cells requires
MHC-I expression, which has long been considered to be absent
in the CNS. This paradigm of CNS immune privilege needed
correction because MHC-I expression is possible, though tightly
regulated in the CNS. Whereas microglia, perivascular macro-
phages, and endothelial cells constitutively express MHC-I, it is
usually below detection limits in astrocytes, oligodendrocytes,
and neurons.However,MHC-I has been found to be upregulated
in multiple sclerosis lesions on glial cells and neurons in the le-
sions (Ho¨ftberger et al., 2004). For example, strong danger sig-
nals under inflammatory conditions, such as the cytokines IFN-
or TNF-, also trigger MHC-I expression in neurons (Neumann
et al., 1995;Medana et al., 2001). Furthermore, it has been shown
that these interactions can have fatal long-term consequences or
only transiently affect the neuron (Meuth et al., 2009). Therefore,
even though MHC-I expression in CNS tissue is low, specific
antigen recognition by CD8T cells apparently occurs, although
the relevance of this antigen recognition has not yet been clari-
fied. There are also reports of the regulatory roles of CD8T cells
within the CNS by direct modulation of CD4 T-cell responses
(Jiang et al., 2003; Hu et al., 2004; Zipp and Aktas, 2006).
Recent advances in deep-tissue imaging have made possible
the monitoring of immune cells in organotypic environments
and the living animal, revealing a direct immune–CNS cell inter-
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action (Nitsch et al., 2004; Siffrin et al., 2010). Using two-photon
laser scanningmicroscopy (TPLSM),wehavepreviously shown that
activated CD8 T cells demonstrate characteristic motility changes
upon antigen recognition in activated organotypic brain slices, re-
sulting in Ca2 elevation in neurons and neuronal cell death when
large amounts of their antigen are applied (Meuth et al., 2009).
In the present study, we identified cross-reactivity of a non-
CNS-specific transgenic T-cell receptor (TCR) on CD8 T cells
with a myelin antigen. This cross-reactivity led to characteristic
antigen recognition motility of these CD8 T cell in the CNS
both in vitro and in vivo. Upon transfer of these CNS-cross-
reactiveCD8T cells, we foundCNS invasion only in the context
of established CD4 T-cell-initiated experimental autoimmune
encephalomyelitis (EAE). However, there was no impact of this
cross-recognition on the disease in our in vivo animal models of
multiple sclerosis, although in vitro data clearly proved their cy-
totoxic potential in the context of the self-antigen.
Materials andMethods
Mice. Ovalbumin-transgenic (OT-1), OT-1xB6.acRFP, OT-1xRag1/,
thy1-EGFPxRag1/, 2d2, B6.acRFP, Rag1/, thy1-TN-XXLxRag1/,
andC57BL/6Jmice were bred under specifically pathogen-free conditions.
For adoptive transfer experiments, we used only female animals. For
active immunization, equal numbers of male and female animals were
used with sex-matched controls. All animal experiments were conducted
according to the German Animal Protection Law.
EAE. Mice were immunized subcutaneously with 150 g of myelin
oligodendrocyte glycoprotein 35–55 (MOG35-55; Pepceuticals) emulsi-
fied in complete Freund’s adjuvant (CFA; BD Difco). Mice received 200
ng of pertussis toxin (List Biological Laboratories) intraperitoneally at
the time of immunization and 48 h later.
For adoptive transfer, naive MOG35–55 TCR-transgenic 2d2 CD4

CD62Lhi cells were cultured as previously described (Siffrin et al., 2010),
and 5 106 blasting cells were injected into each Rag1/mouse. Clin-
ical signs of EAE were translated into clinical score as follows: 0, no
detectable signs of EAE; 0.5, tail weakness; 1, complete tail paralysis; 2,
partial hindlimb paralysis; 2.5, unilateral complete hindlimb paralysis; 3,
complete bilateral hindlimb paralysis; 3.5, complete hindlimb paralysis
and partial forelimb paralysis; 4, total paralysis of forelimbs and hind
limbs (mice with a score3.5 to be killed); 5, death.
T-cell culture. OT-1, OT-1xRAG1/, or OT-1xB6.acRFPmice (6–10
weeks old) were killed and spleen cells were isolated as described
previously (Siffrin et al., 2009). Spleen cells were cultured in 3 
10 6/ml cell culture medium (RPMI 1640 supplemented with 2 mM
L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 10%
fetal calf serum) and stimulated with the respective peptide [ovalbu-
min 257–264 (OVA257–264) or MOG40–54] in the presence of 10 ng/ml
IL-12 and 25 ng/ml IL-18. Cells were kept in cell culture medium
supplemented with hrIL-2 (Chiron Therapeutics) for 7 d. Before cells were
taken for in vitro or in vivo experiments, full and comparable activation was
ascertained by cytokine production capacity, which was measured on day 7
by FACS after stimulation with anti-CD3/28 antibodies.
Proliferation assay. To measure murine T-cell proliferation, spleen
cells from OT-1 mice were isolated and labeled with the fluorescent dye
carboxyfluorescein succinimidyl ester (CFSE). T cells were then preincu-
bated for 15–30min at 37°C in culturemediumand subsequentlywashed
twice in prewarmed RPMI  1% HEPES (RPMI/H). Cells were then
resuspended in 10 ml of prewarmed RPMI/H containing 2.5 M CFSE
and incubated for 10 min at 37°C in the dark. The labeled cells were
washed twice with cold culture medium, counted, and cultured in
48-well plates for 3 d with different peptides in different concentra-
tions. Cells were harvested, washed with FACS buffer, stained with
anti-CD8-APC fluorescent antibody, and measured on a FACSCanto
II (BD Germany).
For OT-1xRAG1/ T-cell cultures, CFSE-labeled spleen cells of
OT-1xRAG1/ were mixed in a 1:3 ratio with CD90-depleted irradi-
ated antigen-presenting cells (APCs) from C57BL/6 mouse spleens.
Cytotoxicity assay. The cytotoxicity of OT-1 T cells was assessed as
follows: target cells (mouse spleen cells) were labeled with 1 M CFSE.
CFSE labeling was performed as described for proliferation. Target cells
were coincubated withOT-1 T cells and antigenic peptides for 20 h. Cells
were then harvested and directly transferred to FACS tubes for measure-
ment on the flow cytometer. Immediately beforemeasurement, 1l of PI
(0.1 g/l) was added to each sample to visualize dead and dying cells.
Samples were then analyzed on a FACSCanto II and analyzed with the
FlowJo software (TreeStar).
Dextramer assay. Antigen specificity was checked by MHC-I/peptide
(H-2 Kb/SIINFEKL, H-2 Kb/SIYRYYGL, H-2 Kb/YRSPFSRVVH-
LYRNG and H-2 Db/YRSPFSRVVHLYRNG) constructs on a dextrane
backbone (produced by Immudex). OT-1 T cells were cultured for 7 d as
described above. T cells were harvested, washed with FACS buffer, and
stained with a single dextramer. Notably, no peptides were added in this
assay. Cells were washed and then stainedwith anti-CD8APC. Cells were
then analyzed on a FACSCanto II and analyzed with the FlowJo software.
Analysis of steric peptide homology. Structural data for the peptides
were obtained from the literature (Clements et al., 2003; Mitaksov et al.,
2007). Sequence and structural comparison of the peptides was per-
formed using Universal Protein Resource database/tools (UniProt) and
DeepView/Swiss-PdbViewer, Swiss Institute of Bioinformatics, version
4.1.0. Depending on sequence similarities and secondary structure of
the peptides, the alignment was reconstructed in 3D. Visualization
was optimized subsequently with PyMOL (Incentive Product;
DeLano Scientific).
Histology. Mice were killed under deep anesthesia by intracardial per-
fusionwith PBS followed by perfusionwith 4% (w/w) paraformaldehyde
dissolved in PBS. Spleens, spinal cords, and brains were removed and
fixed in 4% paraformaldehyde overnight. Brains were cut at the optic
chiasm level and embedded in paraffin together with the spleen and
spinal cord. The cervical, thoracic, and higher lumbar spinal cordwas cut
into 8–11 3-mm-thick transverse segments before embedding. Four-
micrometer-thick sections were stained for hematoxylin and eosin,
Luxol-fast blue, and periodic acid-Schiff. Immunohistochemistry was
performed using an automated immunostainer (Link48; Dako) and an
avidin-biotin technique. After deparaffinization, intrinsic peroxidase
was blocked by incubation with 3% (v/v) hydrogen peroxide in PBS at
4°C for 20 min. Sections were pretreated for easier antigen retrieval by
microwave. The primary antibodies were rat anti-Mac3 (1:200; BD
PharMingen) or rat anti-CD3 (1:100; Serotec), rabbit anti-MBP (1:1000;
Dako), and neurofilament (1:3000; Abcam). Sections were incubated
with secondary biotinylated anti-mouse (ready to use-solution; Dako),
anti-rat (1:400; GE Healthcare), or anti-rabbit (1:400; Vector Laborato-
ries) antibodies and avidin-peroxidase (ready to use solution; Dako) for
1 h at room temperature. 3,4-Diaminobenzidine was used as the color
substrate and sections were mounted with Eukitt mounting medium
after dehydration. MBP staining was performed for analysis of demyeli-
nated areas and neurofilament staining was performed for identification
of neuronal/axonal loss. For analysis of axonal loss in EAE lesions, spinal
cord slices were analyzed by bright-field microscopy using an Olympus
microscope (BX-51) and photographed with anMBF Bioscience camera
controlled via the software Stereo Investigator 9 (MBF Bioscience). Pic-
tures of brain lesions and healthy tissue were taken with a 60 oil-
immersion objective [1.35 numerical aperture (NA)] and the total area of
neurofilament (NF) staining wasmeasured withMBF ImageJ. NF reduc-
tion in lesions was determined relative to unaffected brain tissue.
Brain slice two-photon laser scanning microscopy. Four-hundred-
micrometer-thick hippocampal slices fromC57BL/6 p10–p12 pups were
prepared as described previously (Siffrin et al., 2009) and kept in recir-
culating, hyperoxygenated, and warmed ACSF. T cells were pipetted
upon the slice and allowed to enter the slice for30min before imaging;
image acquisition was usually performed for5 h per slice.
When indicated, antigen OVA257–264, OVA323–339, or MOG40–54 was
added through the perfusion. Cells were visualized in acute hip-
pocampal slice cultures by a two-photon system SP2 (Leica) equipped
with an upright microscope fitted with a 20 water-immersion ob-
jective (NA 0.5; Leica). Cell recognition, cell tracking, and 3D presen-
tation were performed with Volocity (Improvision). Statistical
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analysis and graphical presentation were performed with GraphPad
Prism 5 software.
Intravital two-photon laser scanning microscopy. Mice were anesthe-
tized and the brainstem exposed as described previously (Siffrin et al.,
2010). During surgery and microscopy, body temperature was main-
tained at 35–37°C. We used near infrared excitation as described previ-
ously (Siffrin et al., 2010). Cell recognition, cell tracking, and 3D
presentation were performed with Imaris Software (Bitplane). Stratifica-
tion of tracks as referring to stopping cells (3m/min), swarming cells
(3 m/min6 m/min), and nonrestricted cell movement (6 m/
min) has been described previously (Moreau et al., 2012) and was
adapted here because of x-/y-/z-drift. Statistical analysis and graphical
presentation were performed with GraphPad Prism 5 software.
Ca2 determination. Briefly, the intracellular Ca2 sensor is based on
a FRET pair; that is, cerulean fluorescent protein (CFP derivative) as a
donor and citrine [yellow fluorescent protein (YFP) derivative] as an
acceptor, bound to troponin C in such a way that Ca2-induced confor-
mation changes of troponin C are directly translated in modifications of
the FRET signal; that is, in modifications of the citrine/cerulean ratio.
Therefore, relative Ca2 changes can be intravitally visualized inmice, as
described previously (Heim et al., 2007; Siffrin et al., 2010), by comput-
ing the ratio of citrine emission (535 nm, spectral width 50 nm) and
cerulean emission (475 nm, spectral width 40 nm) after excitation at 850
nm. Performing FRET-based calcium titrations, the sensor is very suit-
able for determining pathological calcium concentrations, although it
may not be suitable for resolving very subtle increases in physiological
calcium (Mank et al., 2008). The treatment of neuronal tissue with iono-
mycin leads to themaximal possible saturation (ceiling level) of troponin
C with Ca2 in living neurons/axons. Therefore, in all intravital experi-
ments, we related themeasured the YFP/CFP ratio to themaximum ratio
measured after addition of ionomycin and expressed the relative Ca2
concentration as a percentage of this maximum ratio (R/R [%]).
Thereby, we assumed a linear dependence of the binding affinity of tro-
ponin C to Ca2, as described previously (Heim et al., 2007).
Results
OT-1 T cells can be efficiently activated byMHC-I/MOG40–54
because of cross-reactivity of OVA257–264 with the myelin
peptide MOG40–54
OT-1 TCR-transgenic CD8 T cells recognize an ovalbumin
peptide (OVA257–264), an antigen that is not expressed in mam-
malian brains. MOG40–54 has been described as a CD8-related
self-antigenic epitope of theMOGprotein inC57BL/6mice in the
context of EAE and is presented in association with H-2Db (Sun
et al., 2003).We found thatOT-1T cells recognized not only their
cognate (foreign) antigen OVA257–264, but also the myelin pep-
tide MOG40–54. We confirmed this cross-recognition or molecu-
lar mimicry by three independent read-outs in conventional
CD8 T-cell–peptide–MHC-I recognition assays. First, we
checked the proliferative potential of the self- and cross-reactive
peptide. OT-1 T cells proliferate vigorously in the presence of the
lowest concentrations of OVA257–264 (500 pM–50 nM), proving
the high avidity of OVA257–264/MHC-I/OT-1 TCR complexes.
We found that the myelin peptide MOG40–54 induced con-
centration-dependent OT-1 T-cell proliferation (Fig. 1A), which
showedmaximal activation of OT-1 T cells comparable to the cog-
nate OVA257–264 at 50 M MOG40–54 (Fig. 1B). This antigen
concentration is comparable to those known from autoanti-
gens in other contexts (Bettelli et al., 2003; Sun et al., 2003;
Perchellet et al., 2004), which have been shown in range of
1–100 M.
Second, we confirmed the cross-reactivity by proving the cy-
totoxic potential ofMOG40–54-activated OT-1 T cells through an
APC-based cytotoxicity assay, which showed specific cytotoxicity
of OT-1 T cells in the presence of MOG40–54 at a dose of 50 M
(Fig. 1C), which was the minimal dose needed for maximal
proliferation.
Third, we used MHC-I dextramers, fluorescently labeled,
ready-to-use MHC-I/peptide multimers that can be used to de-
tect antigen specificity of T cells.We identified specific binding of
both OVA257–264 and MOG40–54 in the context of the MHC-I
H-2Kb toOT-1CD8T cells (Fig. 1D, top). Control polyclonally
activated wild-type CD8 (pcCD8) T cells did not show any
binding to any of the tested dextramers, which underlines the
specificity ofOT-1/H-2Kb/MOG40–54 binding (Fig. 1D, bottom).
Steric homology was obvious in the analysis of the TCR binding
motif because the secondary structure of the MOG peptide ex-
posed a strongly homologous motif with OVA257–264 (Fig. 1E).
This supports the previously described idea of true molecular
mimicry of the TCR binding part of largely nonidentical peptides
(Sandalova et al., 2005), in our case OVA257–264, which has no
strong sequence homology with the MOG peptide. These results
prove that cross-recognition of MOG40–54 peptide by OT-1 T
cells leads to fully activated and functionally similar T cells by
both the foreign antigen and the self-antigen, whereas the re-
quired doses for the cross-reactive peptide are much higher than
for the cognate peptide.
To rule out any artifacts of the peptide synthesis or peptide
solving procedures, we investigated several similarly synthesized
and dissolved peptides; for example, the control peptide LCMV
gp33–40 from lymphocytic choriomeningitis virus glycoprotein
(cognate peptide of theMHC-I-dependent transgenic TCR P14),
which did not induce any proliferation (data not shown). To
exclude contamination with nontransgenic TCR chains (recom-
bination with endogenous TCR chains), we performed similar
experiments with RAG-1/  OT-1 lymphocytes (no endoge-
nous TCR rearrangements), which confirmed correct TCR ex-
pression (data not shown).
OT-1 CD8 T cells, but not OT-2 CD4 T cells, show antigen
recognition motility upon cognate antigen application in
organotypic brain slices
To investigate the effects of the cross-recognition of a myelin
peptide by OT-1 CD8 T cells identified in vitro within CNS
tissue, we used a T-cell/brain slice coculture model (Meuth et al.,
2009). We cocultured these organotypic slices with TCR-
transgenic CD8 (OT-1) or CD4 (OT-2) T cells, which recog-
nize peptides from chicken OVA, a protein that is not expressed
in mice. In vitro-activated, IFN--producing, and cell tracker
(CMTMR)-labeledOT-1CD8T cells (Fig. 2A) were transferred
onto an acute hippocampal slice, into which they rapidly entered.
OT-1 CD8 T cells (Fig. 2B) homogenously exhibited continu-
ous propulsivemotility. To identify the effect of antigen presence
in the organotypic environment, we added 25 nM OVA257–264
peptide (OT-1 cognate antigen) about 60 min after OT-1 CD8
T cells had entered the slice (Fig. 2A, right). Quantitative analysis
revealed a strong decrease in instantaneous velocity for OT-1 T
cells immediately after antigen application (Fig. 2C; for time lapse
representation, see alsoFig. 2F).OT-1CD8Tcells showedahighly
significant increase in the percentage of cells with stationarymotility
from 10.3% to 69.4% after OT-1 OVA257–264 (CD8-OVA) applica-
tion (Fig. 2D). In contrast, OVA323–339 (CD4-OVA) application did
not increase the relative number of stationary cells in the OT-2
CD4T-cellhippocampalcocultures (Fig.2E).This lackof response
of theOT-2CD4Tcells is due to the absenceofMHC-IImolecules
in our slices, which in general is necessary for full activation (Neu-
mann et al., 1996; Celli et al., 2007).
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Together, our findings reveal that CD8 T cells have the po-
tential to recognize their cognate antigen in organotypic CNS
tissue and thatMHC-I expression in these brain slices is sufficient
to induce stopping motility in CD8 T cells.
OT-1 T cells recognize the myelin peptide MOG40–54 in acute
hippocampal brain slices
Upon application of OVA257–264 or MOG40–54 on perfused OT-1
CD8 T-cell brain slice cocultures, a slowing down to stationary
motility was observed under both conditions (Fig. 2F). There-
fore, we observed cross-recognition ofMOG40–54 byOT-1CD8

T cells, although there was no obvious sequence homology (Fig.
2G). The motility changes upon addition of MOG40–54 to the
OT-1 CD8 T-cell brain slice cocultures were concentration de-
pendent (Fig. 2H, I). When MOG40–54 was applied at a low con-
centration of 25 M (2.5 cell culture concentration), the mean
displacement rate and mean instantaneous velocity showed only
a minor reduction, which was in the range of unspecific changes
similar to with the control peptide OVA323–339 (Fig. 2H). In
higher dose ranges (200 M	 20 cell culture concentration),
MOG40–54 led to similar changes to the cognate peptideOVA257–264
(Fig. 2C,I). This was in clear contrast to the application of high
concentrations of the control peptide (12 M OVA323–339, 20
 cell culture concentration; Fig. 2H). For the mean instanta-
neous velocity, there was a dose-dependent effect of the three
tested concentrations (Fig. 2I). In this way, we identified a cross-
reactivity of the OVA257–264-specific OT-1 TCR with MOG40–54.
Transfer of activated OT-1 CD8 T cells into lymphopenic
hosts does not lead to autoimmunity in vivo
To investigate the relevance of the observed cross-recognition of
a foreign and a self-antigen in vivo, we used two separate experi-
mental approaches. In one set of experiments, we injected acti-
vated OT-1 T cells (constitutively expressing tdRFP) or, as a
control, activated pcCD8 T cells (constitutively expressing
CFP) into naive B6.RAG-1/ thy1.EGFPmice (lymphopenic
mice that express EGFP in axons; Siffrin et al., 2010). The animals
were monitored for weight loss for 26 d and clinically evaluated
according to EAE function scores. Transfer of activated OT-1 T
cells did not lead to any clinical symptoms of disease, not even
weight loss, which is the most sensitive sign at the beginning of
the disease (Fig. 3A). Consistent with this, TPLSM of the brains-
tem of living, anesthetized mice showed that only a few of the
activated OT-1 T cells and control polyclonal (pc) CD8 T cells
were present in the CNS,most likely in the perivascular area (Fig.
3B). The transfer of both populations together in one mouse was
for reasons of internal control (experimental group: OT-1, con-
trol group: wild-type pcCD8 T cells) in TPLSM. This is neces-
Figure 1. Cross-recognition of the myelin peptide MOG40–54 by OT-1 T cells. A, Spleen cells of OT-1 mice were isolated, labeled with CFSE, and then stimulated with different concentrations of
antigenic peptides. MOG40–54 induced concentration-dependent OT-1 T cell proliferation in this 3D CFSE proliferation assay. The presented data are representative of at least three experiments. B,
Quantification of proliferation assays (as shown inA) reveals full activation, that is, comparable activation to stimulation by cognate antigenOVA257–264, of OT-1 T cells by aMOG40–54 concentration
of 50M. C, The cytotoxic potential ofMOG40–54-activated OT-1 T cells is shown by specific lysis of CFSE-labeled APCs (target cells). PI incorporation in CFSE-positive cells has been analyzed by FACS
after 20 h of incubationwith preactivated OT-1 T cells and the antigenic peptides; data are representative of at least two independent experiments.D, The specificity of the cross-reactivity of CD8
OT-1 T cells is confirmed by use of MHC-I-/peptide multimers (dextramers). Specific binding of OVA257–264 and MOG40–54 is identified in the context of the MHC-I H-2Kb to OT-1 CD8
 T cells. As
controls, the 2C TCR-specific dextramer (H-2Kb/SIYRYYGL) and the H-2Db/MOG40–54 multimer do not show binding to the OT-1 TCR. Polyclonal CD8
 T cells do not show specific binding of any of
themultimers (bottom); data are representative of two independent experiments. E, Structural data of the peptidesMOG40–54 (purple) and OVA257–264 (green)were visualized and comparedwith
DepView/Swiss-PdbViewer (Swiss Institute of Bioinformatics), which showed steric overlap of the central parts of the molecules.
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sary because the brainstem of mice and the lesion distribution
and morphology is variable in between different mice.
On day 25, immune cells were isolated from the spleen and
CNS of the separately cotransferred mice. In the spleen, large
numbers of the transferred CD8 T cells were found (Fig. 3C);
within the CNS, only very few of these cells were identified (Fig.
3D). Upon restimulation with plate-bound anti-CD3/anti-CD28
antibodies, strong IFN- production was recalled similarly for
control andOT-1 CD8T cells isolated from the spleen (Fig. 3E)
or the CNS (Fig. 3F). Therefore, in the absence of disease induc-
tion by CD4 T cells, the cross-reactivity of a myelin antigen by
CD8 T cells did not induce CNS inflammation. This indicates
that only a few activated myelin-specific CD8 T cells can reach
or be retained in the CNS under steady-state conditions in the
absence of CD4 T cells.
Transfer of activated OT-1 T cells and pcCD8 T cells into
ongoing EAE leads to selective recruitment of OT-1 T cells to
inflammatory lesions
To investigate whether activated OT-1 T cells recognize their
cognate antigen in established EAE lesions, we induced the dis-
ease by transfer of MOG-transgenic CD4 (2d2) Th17 cells in
lymphopenic B6.RAG-1/ thy1.EGFP (green fluorescent ax-
ons) mice (Siffrin et al., 2010).We previously investigated CD8
T cells in active EAE, in which endogenous CD4 and CD8 T
cells enter the CNS (Leuenberger et al., 2013). Based on these
observations, we chose the adaptive transfer model (2d2 Th17
transfer to induce the disease) here to have a situation without
endogenous CD8 T cells and thus to compare OT-1 versus
pcCD8 T cells, which had clear and similar stimulation
conditions.
For TPLSM, we cotransferred both OT-1 T cells (constitu-
tively expressing tdRFP) and control polyclonally stimulated
CD8 T cells (constitutively expressing CFP) into these mice,
similarly as in the experiment for Figure 3B. The rationale for the
cotransfer was to have both populations in onemouse for reasons
of internal control in imaging. After transfer of both CD8 T-cell
populations in EAE mice, we detected high numbers of CD8 T
cells infiltrating the CNS as sign of selective enrichment of OT-1
T cells compared with pcCD8 T cells (Fig. 4A,D; Video 1). Cell
tracking analysis revealed a complex motility pattern of OT-1 T
cells and pcCD8 T cells in respect to the axonal compartment
(Fig. 4B,C). Comparedwith the polyclonal CD8T cells, OT-1T
cells exhibited a significant reduction in mean displacement rate
Figure 2. OT-1 CD8 T cells in organotypic brain slices. A, In vitro-activated OT-1 CD8 T cells (left) in an acute hippocampal slice show continuous propulsive motility (scale bar, 100m),
characterized by a round leading edge (arrowhead) and a trailing uropod (asterisk) as shown inmagnification (scale bar, 10m). The addition of 25 nMOVA257–264 peptide resulted in rounding and
stopping of OT-1 CD8 T cells (A, right), a typical behavior of antigen recognizing cells.B, Quantitative analysis ofmean instantaneous cell velocity reveals continuously high velocity of OT-1 CD8
T cells in the absence of antigen (36 cells tracked, mean
 SEM). C, After application of 25 nM OVA257–264, instantaneous velocity of OT-1 T cells decreases strongly (Mann–Whitney-U test; ***p
0.0001, 26 cells, mean
 SEM).D, Static cells amongOT-1 CD8 T cells showhighly significant increases, from10.3% to 69.4%, after OT-1 OVA257–264 application (Mann–Whitney-U test; ***p
0.0001, mean
 SEM). E, Similar experiments with OT-2 CD4 T cells show that OVA323–339 (CD4-OVA) application does not increase the number of stationary cells in the OT-2 CD4
 T-cell
hippocampal cocultures (mean
 SEM). F, OVA257–264 application leads to rounding of the formerly ovoid and propulsive OT-1 cells. Similarly, 200 M MOG40–54 induces a slowing down to
stationary motility. Peptides were added 10 min after starting the time-lapse acquisition (start of antigen application in respect to the depicted tracks is marked with an arrowhead; scale bar, 10
m). G, Amino acid sequence of OVA257–264 and MOG40–54. H, The stopping motility (mean displacement) induced by MOG40–54 is concentration dependent. In contrast, the control peptide
(OVA323–339) does not induce motility changes (Kruskal–Wallis test; Dunn’s post test). I, Mean instantaneous velocity (
 SEM) of OT-1 T cells is shown for each time point and each condition
compared with before application of the substance. Concentrations of 25, 100, or 200M MOG40–54 have been compared with the baseline in the same experiment (Mann–Whitney-U test; *p
0.05, ***p 0.0001). All data are representative of at least three experiments.
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(Fig. 4E), which is indicative for antigen recognitionmotility.We
detected highly motile infiltrating T cells in areas of intact axons
(Fig. 5A, green box; Video 2), both OT-1 T cells and, in lower
numbers, polyclonal CD8 T cells (Fig. 5B, Video 3). T-cell
tracking revealed undirected cell paths but often with regional-
ized migration (Fig. 5D, top). We identified areas of injured ax-
ons (Fig. 5A, red box) via focal swellings or fragmentation
(Kerschensteiner et al., 2005; Siffrin et al., 2010) and observed
more OT-1 T cells with directive and also stationary migratory
paths, which was in clear contrast to polyclonal CD8 T cells
(Fig. 5C,D, bottom). Analysis of cellmotility in bothCD8T-cell
groups revealed a reduced displacement rate of OT-1 CD8 T
cells compared with the polyclonal CD8 T cells (Fig. 5E) and
also between OT-1 T cells near damaged axons and OT-1 T cells
near intact axons. This indicates that cross-recognition takes
place under inflammatory conditions and ismore pronounced in
more severe lesions. Statistical analysis of the track motility pat-
tern was performed as described previously with slight adapta-
tions to our system [stopping cells (3 m/min), swarming/
kinapse cells ( 3 m/min6 m/min), and nonrestricted cell
movement (6 m/min)]. This analysis confirmed the observa-
tion that antigen recognition was found mainly in OT-1 T cells
and rarely in pcCD8 T cells (Fig. 5F). In addition, areas with
injured axons had higher numbers of stopping and swarming
OT-1 T cells than areas withmorphologically intact axons, which
might correlate with the presence of disrupted myelin. However,
direct interactions with axons could not be confirmed (Fig.
6A,B), in contrast to CD4 T-cell interactions with axons (Fig.
6C,D, red, 2d2 Th17 cells; Video 4), which we have described
previously in detail (Siffrin et al., 2010).
Figure 3. Transfer of activated OT-1 CD8 T cells into lymphopenic mice. OT-1 spleen cells were activated by 50 nM OVA257–264 in the presence of IL-12 and IL-18. As the control, anti-CD3/anti-
CD8 polyclonally activated wild-type C57BL/6 spleen-derived CD8 T cells were similarly activated. A total of 5 10 6 activated CD8 T cells were injected on day 7 of culture into naive
lymphopenic Rag1/mice (n8, data representative of twoexperiments).A, CD8 T-cell-transferredRag1/miceweremonitored forweight loss for 26d and clinically evaluated according
to EAE function scores. B, TPLSM of the brainstem of living anesthetized Rag1//thy1-EGFP mice, which had been injected with red-fluorescent OT-1 cells and blue fluorescent pcCD8 T cells,
showed only a few, most likely perivascular, activated OT-1 T cells and control pcCD8 T cells in the CNS without signs of CNS tissue invasion (representative of six imaging areas from two
experiments; scale bar, 30m). C, On day 25, immune cells were isolated from spleens in which large numbers of the transferred CD8 T cells could be found. D, In the same animals as in C, only
very few cells in total and low numbers of transferred CD8 T cells (OT-1 or pcCD8 T cells) could be found by flow cytometry in CNS isolated immune cells (single dot represent single cells; pooled
CNS samples from three animals). E, Upon restimulation with plate-bound anti-CD3/anti-CD28 antibodies, strong IFN- production was recalled in the same way for both control and OT-1 CD8
T cells isolated from the spleen or the CNS (F ).
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MOG40–54 reactive OT-1 T cells do not induce clinical or
subclinical damage in EAE lesions despite antigen recognition
motility
Next, we investigated the association of CD8 (MOG-recogniz-
ing; Fig. 7A, Video 5) and CD4 T cells (MOG-recognizing; Fig.
7B, Video 6)with intra-axonal Ca2 increase, which is the earliest
sign of axonal damage even before morphologic changes. We
usedmice that express a genetically encoded Ca2 sensor in neu-
rons and axons (thy1-TN-XXL; Mank et al., 2008) in a similar
experimental approach as that for the thy1-EGFP mice. Here, we
could confirm that the specific interactions of CD8 T cells with
axons were rather subtle (Fig. 7C), whereas the CD4 T cells
often enwrapped the whole axon for a prolonged period of time
(Fig. 7D). On the functional level, the latter form of contact was
associated with higher intra-axonal Ca2 levels in the axons in
contact with CD4 T cell (Fig. 7E) than those in contact with
CD8 T cells (Fig. 7F).
To change the focus from intravital imaging to clinical evalu-
ation of CD8-mediated damage processes, we switched frompas-
sive to active EAE, which usually leads to a less severe disease
course and therefore allows longermonitoring.We cotransferred
activated OT-1 CD8 T cells on day 7 after active EAE induction
(Fig. 8A). Control mice received polyclonally activated wild-type
CD8 T cells on day 7. The positive control was a group of mice
that received 2d2 Th17 cells, which induces a neurodegenerative
phenotype when transferred into active EAE (Siffrin et al., 2010);
the negative control group received a saline injection. The sever-
ity of clinical signs did not differ between the CD8 transferred
Figure 4. Transfer of activated OT-1 T cells into ongoing EAE. EAE was induced in Rag1//thy1-EGFP mice (green fluorescent axons) by transfer of MOG35–55 TCR transgenic 2d2 CD4
 Th17
cells. Both OT-1 CD8 T cells and control polyclonal (pc) CD8 T cells were cotransferred 7 d after 2d2 transfer. OT-1 T cells (constitutively expressing tdRFP) and control pcCD8 T cells
(constitutively expressing CFP) had been activated in the presence of IL-12 and IL-18. For TPLSM, both CD8 T-cell subsets were cotransferred together in recipient animals (n 18, data
representative of six experiments). A, CNS-infiltrating cells revealed red OT-1 cells and blue CFP cells with more OT-1 than pcCD8 (imaging area: 300 300 70m). B, High-contrast depiction
of EGFP fluorescent structures (axons). C, Display of individual cell tracks (OT-1 in red, pcCD8 in blue) of the recording as shown in A reveals complex motility pattern of OT-1 and pcCD8 in EAE
lesions (observation time45min).D,Mean cell numbersper timepoint ofOT-1orpcCD8T cellswereanalyzed for 12 time-lapse recordings from18 recordingsof six experiments.OT-1 cells strongly
outnumbered pcCD8 T cells in EAE lesions; Mann–Whitney-U test was performed; ***p 0.0001. E, Mean displacement rate of OT-1 or pcCD8 T cells from cell tracking analysis as shown inD
are displayed. OT-1 have a lower displacement rate than pcCD8, which indicates a higher number of antigen recognizing CD8 T cells in the OT-1 population (Mann–Whitney-U test; ***p
0.0001).
Video 1. Intravital imaging of living anesthetized CD4-induced EAE (nonfluorescent 2d2
Th17 cells for induction) in RAG1/  thy1-EGFP mouse (axons in green) that had been
transferred with OT-1 (red) and pcCD8 T cells (CFP).
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groups (activated OT-1 or polyclonal CD8 T cells), whereas the
2d2 Th17 transferred mice underwent a more severe disease
course. Both CD8 T-cell subsets showed a strong activation
phenotype before transfer (Fig. 8B) andwe identified a significant
number of the transferred CD8 T cells. Upon re-isolation of T
cells from mice that had received both CD8 T-cell subsets
(OT-1 plus pcCD8 T cells), we were able to detect OT-1 T cells
and pcCD8 T cells in the spleen and CNS. Consistent with the
findings from the TPLSM results of the adoptive transfer EAE
model described above, OT-1 T cells were enriched in the CNS.
MoreOT-1 T cells were recruited than pcCD8T cells compared
with reference ratios from the spleens (Fig. 8C,D). In addition, in
the CNS, there were significantly more IFN- producers among
OT-1 T cells than among the polyclonal CD8 T cells (Fig. 8E),
indicating once more either selective enrichment of these
strongly activated OT-1 T cells or local reactivation. To evaluate
subclinical damage processes in the context of either OT-1 or
pcCD8 T cells, we performed standard histology from animals
Figure 5. Analysis of CD8 T-cell motility in relation to axonal injury. In the recordings, as shown in Figure 4, the interaction between OT1 or polyclonal CD8 T cells with axons was analyzed.
Some axons show typical signs of damage (swellings, fragmentation, ellipsoid bodies) due to EAE pathology; othersweremorphologically intact. Image areaswith damaged axons (red boxed area)
were compared with areas without damage (green boxed area). A, Overview high-contrast depiction of EGFP fluorescence (axons), two relevant sections are enlarged to highlight areas of axonal
integrity (green frame) and axonal injury (red frame), which are found close to each other. Injured axons are characterized by focal swelling and an irregular shape of axon cross section. B, In areas
of intact axons (green frame inA), bothOT-1 andpcCD8 T cells exhibit propulsivemotility/morphology.C, In areas of injured axons (red frame inA), OT-1 T cells show roundingas a signof stopping.
D, Depiction of individual cell paths (OT-1: red, pcCD8: blue) in area of intact (top) versus injured (bottom) axon(s). E, Analysis of several recordings similar to A reveals a decrease in mean
displacement rate in areas of injured axons compared with intact areas (18 individual recording from six experiments, Mann–Whitney-U test; *p 0.025). F, Analysis of mean velocity and
stratification of cell trackswith stationarymotility (3m/min), swarmingmotility (3 and6m/min), and randommigration velocity (6m/min) from18 individual recordings from six
experiments. The percentage of cells with the respective motility pattern is shown.
Video 2. Intravital imaging of living anesthetized CD4-induced EAE (nonfluorescent 2d2
Th17 cells for induction) RAG1/ thy1-EGFPmouse (axons in green) that had been trans-
ferred with OT-1 (red) and pcCD8 T cells (CFP). OT-1 T-cell migration can be seen near intact
axons.
Video 3. Intravital imaging of living anesthetized CD4-induced EAE (nonfluorescent 2d2
Th17 cells for induction) RAG1/ thy1-EGFPmouse (axons in green) that had been trans-
ferredwith OT-1 (red) and pcCD8 T cells (CFP). OT-1 T-cell migration can be seen in respect to
injured axons.
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that were killed on day 22 (14 d after CD8 T-cell transfer).
Histopathological semiquantitative analysis revealed that the
characteristics of invading immune cells were similar in both
groups (Fig. 9A,B). The extent of demyelination was analyzed by
semiquantitative evaluation of MBP loss in white-matter tracts,
which showed no differences between the groups (Fig. 9C). In
addition, the extent of axonal damage was comparable between
the two groups, as identified by similar loss of neurofilament-
positive neurons/axons in demyelinated lesions (Fig. 9D). There-
fore, we did not find any differences in damage either to myelin
sheaths or to axons/neurons in EAE lesions, although strongly
activated and enrichedOT-1 T cells were found in high numbers.
In summary, we showed that there is specific recognition of
MOG40–54 by OVA-transgenic (OT-1) CD8
 T cells in the CNS
in vivo but that this was not sufficient to induce either clinically or
subclinically detectable CNS damage.
Discussion
The role of CD8T cells in the pathology ofmultiple sclerosis has
been the subject of controversy for many years (Neumann et al.,
2002; Siffrin et al., 2007; Friese and Fugger, 2009). We made use
of this model of myelin-recognizing transgenic CD8 T cells to
analyze the intriguing model of molecular mimicry for the first
time in EAE lesions in vivo by TPLSM. Myelin cross-reactive
OT-1 T cells exhibited characteristic antigen-recognition motil-
ity changes in areas of axonal injury without the need for exoge-
nous antigen application. Therefore, these cross-reactive, highly
activated CD8 T cells were markedly enriched in the CNS, but
only in established EAE lesions. Nevertheless, these myelin-
recognizing, activated CD8 T cells did not result in CNS dam-
age within the CNS under in vivo conditions; that is, in naive
lymphopenic mice or in ongoing autoimmune CNS inflamma-
tion in EAE mice.
The strongest arguments in support of an active role of CD8
T cells in the pathology of autoimmune neuroinflammation have
been derived from studies of the human disease, which describe
the presence of CD8 T cells in multiple sclerosis lesions (Babbe
et al., 2000; Kim et al., 2012; Siewert et al., 2012). These reports
have fueledmany approaches for finding animal models of CD8-
mediated neuroinflammation. However, genuine CD8-induced
EAE models are much rarer than CD4-mediated EAE models,
which come inmany different forms (Krishnamoorthy andWek-
erle, 2009). Whereas the relevance of CD4 T cells, in particular
for autoimmune demyelinating neuroinflammation (Petermann
and Korn, 2011), is undeniable, the contribution of CD8T cells
to CNS damage ismuchmore controversial. There have been two
studies showing a clear disease-inducing role of CD8 T cells by
transfer ofmyelin-specific CD8T cells (Huseby et al., 2001; Sun
et al., 2001). In contrast, the majority of studies emphasize very
mild, EAE-uncharacteristic or even absent clinical deficits com-
paredwith theCD4T-cell-mediated disease (Ford andEvavold,
2005; Friese et al., 2008; Saxena et al., 2008; Ji et al., 2010; Ander-
Figure 6. Analysis of interactivity of T cells with axons. EAE was induced in Rag1//thy1-EGFP mice (green fluorescent axons) by transfer of MOG35–55 TCR-transgenic 2d2 CD4
 Th17 cells.
Both OT-1.tdRFP CD8 T cells and control polyclonal (pc) CD8 T cells (CFP) were cotransferred 7 d after 2d2 transfer. A, Area of axonal injury with numerous OT-1 T cells (red), which exhibit
stationarymotility; pcCD8 T cells with freemigration. Right, Analysis of cell tracks (OT-1: red, pcCD8: blue).B, 360° rotation along the y-axis of the boxed area (white) in A. Arrows indicate the
distance between axons andOT-1 C8 T cells. C, EAEwas induced in Rag1//thy1-EGFPmice (green fluorescent axons) by transfer of red-fluorescentMOG35–55 TCR-transgenic 2d2.tdRFP CD4

Th17 cells. 2d2.tdRFP Th17 cells (red, arrow) interact with axons. Axon exhibits thinning after interaction with 2d2 Th17 cell as sign of imminent dissection (arrowhead). D, Rotation along a
horizontal axis of image area in C shows close proximity of axons and 2d2.tdRFP Th17 cell (arrow).
Video 4. Intravital imaging of living anesthetized RAG1/ thy1-EGFPmouse (axons in
green) mouse that had been induced for EAE by red-fluorescent 2d2 Th17 CD4 T cells (red).
CD4 T-cell interaction with axon can be seen.
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son et al., 2012; Na et al., 2012). In addition, inmost of these CD8
models, the assistance of CD4 T cells seems to be essential for
full-blown autoimmune neuroinflammation (Leuenberger et al.,
2013).
The basic requirements for specific antigen recognition of
CD8 T cells is presentation byMHC-I molecules (Townsend et
al., 1989). In this study, using intravital imaging, we discovered
that, in principle, OT-1 T cells are able to recognize both their
Figure 7. In vivo intra-axonal Ca 2 evaluation to quantify axonal injury in relation to T-cell interactions. EAE was induced in Rag1//thy1-TN-XXL mice (genetically encoded
troponin-C based Ca 2 sensor) by transfer of MOG35–55 TCR transgenic nonfluorescent 2d2 CD4
 Th17 cells (A, C) or red fluorescent 2d2.tdRFP Th17 cells (B, D). Ca 2 levels are shown
as the YFP/CFP ratio; data representative of at least three independent experiments. A, Activated, red-fluorescent OT-1.tdRFP CD8 T cells and control polyclonal (pc.EGFP) CD8 T cells
were cotransferred 7 d after 2d2 transfer. As in Figures 4 and 5, interactions of CD8 T cells were visualized. Intra-axonal Ca 2 is shown as the ratio channel (heat map: blue-red). Only
few axon-associated OT-1.tdRFP cells were associated with increased intra-axonal Ca 2 levels. B, Disease-inducing 2d2.tdRFP Th17 cells strongly associated with high Ca 2 axons. C,
3D time-lapse imaging of the boxed area in A is shown and reveals the subtle contact formation (arrowhead) of static OT-1.tdRFP cells with axons (CFP channel: blue, YFP channel: yellow).
D, 3D time-lapse imaging of the boxed area in B is shown and reveals the strong contact formation (arrowhead) of the 2d2.tdRFP cell with an axon that is tightly enwrapped by the T
lymphocyte. E, 2d2.tdRFP CD4 T cell (arrow in D) contacted axon. Mean relative Ca 2 levels in contacted axon 1 compared with control axon with no T-cell contact in the same
recording. F, OT-1.tdRFP CD8 T-cell-contacted axon 2 (arrow in C). Mean relative Ca 2 levels in the contacted axon compared with a control axon with no T-cell contact in the same
recording.
Video 5. Intravital imaging of living anesthetized CD4-induced EAE (nonfluorescent 2d2
Th17 cells for induction) RAG1/ thy1-TN-XXLmouse (axons in blue, Ca 2 yellow-white)
that had been transferredwith OT-1 (red) and pcCD8 T cells (blue). OT-1 T-cellmotility can be
seen in respect to injured axons.
Video 6. Intravital imaging of living anesthetized RAG1/ thy1-TN-XXLmouse (axons
in blue, Ca 2 yellow-white)mouse that had been induced for EAE by red-fluorescent 2d2 Th17
CD4 T cells (red). CD4 T-cell interaction with axon can be seen.
4846 • J. Neurosci., March 25, 2015 • 35(12):4837–4850 Reuter et al. • Cross-Reactive CD8 T Cells in the Brain
(high-affinity) cognate and a (medium-affinity) myelin antigen
in the CNS. CD8T-cell antigen recognition ofMOG40–54 could
be shown by three independent conventional readouts: T-cell
proliferation, cytotoxic activity, and binding of peptide–MHC-I
tetramers. These are three fundamentally different events that
follow the T-cell–APC interaction. Proliferation—similarly to
cytokine production—is a postnuclear response that necessitates
active transcription events. Cytotoxicity is a prenuclear event that
involves the release of preformed vesicles with cytotoxic sub-
stances. Tetramer staining shows the binding of the specific
peptide MHC-I to the TCR. In our slice experiments, this TCR-
MHC/myelin antigen binding resulted in strong changes of mi-
gratory activity in T cells; for example, immobilization (stop
signal) following antigen recognition, which is consistent with
reports using other models (Shakhar et al., 2005). This stopping
motility has been correlated with subsequent cell proliferation,
effector cytokine production, and cytotoxic activity. In contrast,
inefficient TCR-MHC/antigen binding does not induce major
motility changes in vivo (Skokos et al., 2007) and instead results in
T-cell tolerance (Marangoni et al., 2013). Application of these
basic rules of T-cell activation motility highlights the fact that
there is sufficient MHC-I/peptide expression in EAE lesions in
our experiments.
OT-1T cells exhibited full activationmotility in vivo, predom-
inantly in areas of strong axono–glial injury.However, this cross-
reactivity neither increased histological nor intravital signs of
damage nor clinical signs of damage such as weight loss or EAE
symptoms, indicating that CD8 T cells are not the main induc-
ers of damage. Direct observation of the lesions in vivo by TPLSM
showed an induction of sustained Ca2 increase in axons that
were attacked by 2d2 CD4 Th17 cells, but not in axons that
were surrounded by stopping OT-1 CD8 T cells. Despite
these observations, which refute a direct interaction of CD8
T cells with axons and also an effect of stopping OT-1 T cells
on nearby axons, we cannot completely exclude a cell-contact-
independent effect, although neither microscopy nor histology nor
clinical data support damage induction by cross-reactive OT-1
T cells.
It is difficult to reconcile the finding of full reactivation of
cross-reactive CD8 T cells in the CNS in vivo, as we have de-
scribed it here, with the absence of cytotoxicity toward the ax-
ono–glial unit. It is rather unlikely that the activation of T cells in
Figure 8. Evaluation of EAE upon OT-1 T-cell transfer. EAE was induced in C57BL/6 mice by subcutaneous immunization with CFA/MOG35–55. A total of 30 10
6 activated CD8 T cells were
cotransferred on day 7 after EAE induction. A, Mean clinical score of OT-1-cotransferred, pcCD8 T-cell-transferred, or PBS-injected mice were evaluated. There was no significant difference
between the CD8 T-cell-transferredgroups and thePBS control; 2d2 Th17 induceddisease exacerbation comparedwithPBS control and to CD8 T-cell-transferredmice (n7, statistical analysis
of each cell-transferredgroupvsPBS control byMann–Whitney-U test; *p0.05, **p0.01).B, Cytokineexpressionprofile ofOT-1andpcCD8T cells on thedayof transfer into recipient animals
reveals strongandcomparable activationofbothCD8T-cell populations.C, For analysis of selective enrichment,mice receivedbothOT-1andpcCD8T cells analogously to theexperiments shown
in Figures 4 and 5. The ratio of OT-1/CD4 T cells was increased in the CNS comparedwith pcCD8/CD4 T cells within the CNS. These ratios were similar in the spleen. TheMann–Whitney-U test
was performed.D, Spleen-isolatedOT-1 T cells and polyclonal control CD8 T cells exhibited comparable amounts of IFN- producers after in vitro CD3/28 restimulation. E, CNS-isolatedOT-1 T cells
were significantly more numerous IFN- producers than the pcCD8 T cells.
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the CNS is too weak because immobilization—full activation in
areas of destructive EAE lesions—is clearly visible in the
strongly neurodegenerative lesions. However, our imaging ex-
periments showed a lack of direct interactivity of the myelin-
recognizing OT-1 T cells with axons and low association with
intra-axonal Ca 2 increase. Therefore, a buffering of cytotox-
icity by other CNS cells, for example, astrocytes, microglia, or
macrophages, may explain this finding (Sun and Wekerle,
1986). In autoimmunity, these cells may indeed express higher
numbers of MHC-I than neurons and oligodendrocytes.
Another explanation for the lack of cytotoxicity in vivo
could be that the requirements for proliferation and the for-
mation of the cytotoxic synapses are different. It has been
shown that “weak agonists” induced strong proliferation (Ce-
merski et al., 2007) although they did not form the central
supramolecular activation cluster (cSMAC). The cSMAC is
the key feature of a mature immune synapse and it has been
shown to be essential for cytotoxicity (Somersalo et al., 2004).
Anchoring of the microtubule organizing center is strongly
dependent on the presence of a stable LFA-1 supramolecular
cluster that is the backbone for the lytic granule secretion
machinery (Kuhn and Poenie, 2002). Therefore, we cannot
support a direct role of CD8 T cells, which recognize a cross-
reactive self-peptide in the CNS in vivo, in axon damage, in
contrast to what has been described previously for CD4 T
cells (Siffrin et al., 2010) amd shown here for Th17 cells and
axons and elsewhere for macrophages and axons (Nikic´ et al.,
2011). Therefore, we think that it is highly unlikely that cyto-
toxic T lymphocytes (CTLs) indirectly induce axonal damage
in our OT-1–myelin cross-recognizing model. We cannot ex-
clude that, of course, for other CTLs.
This opens up the question of what the basic requirements for
CD8-induced damage in the CNS in the context of medium-
affinity self-antigensmay be. Interestingly, profound tolerance of
MBP-specific CD8 TCR-transgenic mice has been described,
which relied on the active removal of MHC-I/peptide complexes
by high-avidity transgenic CD8T cells without inducing prolif-
eration or disease (Perchellet et al., 2004). In our work, similar
mechanisms were not applicable. We did not find anergy of
CNS-infiltrating, myelin-recognizing CD8 T cells, because
the cross-reacting transgenic CD8 T cells in the CNS showed
even higher IFN- production capacity than the polyclonal
control cells. Several studies have emphasized the potential
role of infectious stimuli in rendering CD8 T cells auto-
reactive in the CNS. Only strong activation of APC, for exam-
ple, via viral infection with the Vaccinia virus, has been shown
to break the tolerance of CD8 T cells and induce CNS auto-
immune disease, which was less reminiscent of demyelinating
disease and more of encephalitis (Ji et al., 2010). Another
study found that ovalbumin-specific CD8 T cells failed to
induce disease in animals with OVA expression in oligoden-
drocytes (Na et al., 2012). Only in the context of intracerebral
Listeria infection were CD8 T cells rendered cytotoxic to-
ward OVA-expressing oligodendrocytes. This indicates that
strong costimulation in addition to TCR signaling is needed
for sufficient CD8 T-cell activation. The need for strong
infectious mediators (Vaccinia, Listeria) underlines the well
known role of CD8 T cells, particularly in the presence of
infection of the CNS. However, this is different from the situ-
ation in EAE and multiple sclerosis, where there are no strong
proinflammatory infectious stimuli (e.g., pathogens in the
CNS).
In the autoimmune context, which by definition has no direct
causative pathogen, the model of molecular mimicry has been
textbook knowledge for many years. Here, we demonstrated in
vivo in the model disease that CD8 T-cell cross-reactivity is
indeed observable in CNS lesions and leads to a selective enrich-
ment of these cells in the CNS. Thismight explain the presence of
oligoclonal CD8 T cells within lesions of multiple sclerosis pa-
tients (Jacobsen et al., 2002). However, that is not sufficient for a
disease-modifying effect.
The question remains of howdamage processes in EAE lesions
are triggered if cross-reactivity of CD8 T cells alone is not suf-
ficient. One suggestion here, supported by experimental but also
recent genetic data, is that the CD4 T cell is also the relevant
subset in the context of direct target organ damage (Nylander and
Hafler, 2012). Considered together, CD8 T-cell-based molecu-
lar mimicry of a foreign antigen and a cross-reactive myelin an-
Figure 9. Histopathological semiquantitative analysis of spinal cord tissue. Standard histopathology was performed on paraffin-embedded tissue samples of animals that had been
killed on day 22 after EAE induction (14 d after CD8 T-cell cotransfer). Shown are the pooled data of two independent experiments (n 10/experiment). A, CNS-infiltrating CD3 cells
are similarly distributed in both groups (representative slide of evaluation). Quantification of CD3 cells shows no significant differences between the OT-1 transferred and the pcCD8
T-cell-transferred groups. Each data spot represents themean cell count per 0.01mm 2 of individual mice. B, Mononuclear phagocytic inflammatory cells (MAC-3 positive) are comparable
in distribution and number in mice that were transferred with OT-1 T cells or polyclonal CD8 T cells. Each data spot represents the mean cell count per 0.01m 2 of individual mice. C,
Demyelination was similar in both groups, as analyzed by semiquantitative evaluation of MBP loss in white matter tracts (percentage of demyelinated area of all white matter area). Each
data point represents the mean of an individual mouse. D, Axonal loss in EAE lesions was evenly distributed between the two groups, as identified by a similar loss of neurofilament-
positive neurons/axons in demyelinated lesions. Each data point represents the mean of an individual mouse. Mann–Whitney-U test was performed for all statistical analyses.
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tigen is not sufficient for inducing axono–glial damage in vivo.
However, it does explain the presence and enrichment of oligo-
clonal and CNS-specific CD8 T cells in EAE. In the end, molec-
ular mimicry on its own is not a plausible cause of either EAE or
potentiallymultiple sclerosis in the context of CD8T cells in the
brain.
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